Disclosure of genetics research results after the death of the patient participant: a qualitative study of the impact on relatives.
When a gene mutation is identified in a research study following the death of the study participant, it is not clear whether such information should be made available to relatives. We report here an evaluation of the impact on relatives of being informed of study results that detected pathogenic BRC...
Main Authors: | Ormondroyd, E, Moynihan, C, Watson, M, Foster, C, Davolls, S, Ardern-Jones, A, Eeles, R |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2007
|
Registos relacionados
-
Communicating genetics research results to families: problems arising when the patient participant is deceased.
Por: Ormondroyd, E, et al.
Publicado em: (2008) -
Is no news good news? Inconclusive genetic test results in <it>BRCA1 </it>and <it>BRCA2 </it>from patients and professionals' perspectives
Por: Ardern-Jones Audrey, et al.
Publicado em: (2010-01-01) -
Disclosure of individual genetic data to research participants: the debate reconsidered.
Por: Bredenoord, A, et al.
Publicado em: (2011) -
Developments in Clinical Practice: Follow up Clinic for BRCA Mutation Carriers: a Case Study Highlighting the "Virtual Clinic"
Por: Ardern-Jones Audrey, et al.
Publicado em: (2004-02-01) -
Researchers’ perspectives on return of individual genetics results to research participants: a qualitative study
Por: Erisa Sabakaki Mwaka, et al.
Publicado em: (2021-01-01)